Research highlights significant sex differences in response to longevity interventions, emphasizing the need for tailored approaches. A comprehensive review underscores that established longevity interventions yield divergent outcomes in male and female laboratory rodents, particularly mice, yet the underlying mechanisms remain largely unexplored. While females generally exhibit longer lifespans, they also endure a greater burden of disease and disability, highlighting the complex interplay between lifespan and healthspan.

The review details various interventions—dietary, genetic, environmental, behavioral, and pharmacological—that have been shown to affect longevity in a sexually dimorphic manner. Notably, it points out that while evolutionary biology has long recognized sex differences in life history traits, the cellular and molecular bases for these disparities in aging responses are still poorly understood. Key factors such as X chromosome regulation, gonadal hormone influences, and ovarian health are identified as critical yet under-researched areas that could illuminate why males and females respond differently to longevity strategies.

The implications for future research are profound. As the field moves towards developing interventions aimed at extending both lifespan and healthspan, integrating sex as a biological variable becomes essential. This shift could lead to the optimization of existing therapies and the creation of sex-specific interventions, ultimately enhancing treatment efficacy for both men and women. Understanding the nuances of these differences could also refine drug development timelines and strategies, ensuring that interventions are effective across the sexes, thereby addressing the unique aging challenges faced by each.

Source: fightaging.org